Talk:MitObesity drugs: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
::::* https://academic.oup.com/function/article/2/6/zqab045/6362606?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6 | ::::* https://academic.oup.com/function/article/2/6/zqab045/6362606?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6 | ||
::::* https://academic.oup.com/function/article/2/6/zqab057/6423774?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6 | ::::* https://academic.oup.com/function/article/2/6/zqab057/6423774?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6 | ||
::::* https://journals.physiology.org/doi/abs/10.1152/ajpendo.00293.2021?utm_source=APSselect&utm_medium=email&utm_campaign=july2022&_zs=XShbW&_zl=LtCA3 | |||
Revision as of 16:47, 2 July 2022
- https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-014-0082-4
- https://academic.oup.com/function/article/2/6/zqab045/6362606?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
- https://academic.oup.com/function/article/2/6/zqab057/6423774?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
- https://journals.physiology.org/doi/abs/10.1152/ajpendo.00293.2021?utm_source=APSselect&utm_medium=email&utm_campaign=july2022&_zs=XShbW&_zl=LtCA3
